Oriola-KD Oyj A (OKDAV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Oriola-KD Oyj A (OKDAV) has a cash flow conversion efficiency ratio of 0.229x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€30.40 Million ≈ $35.54 Million USD) by net assets (€132.60 Million ≈ $155.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Oriola-KD Oyj A - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Oriola-KD Oyj A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Oriola-KD Oyj A (OKDAV) financial obligations for a breakdown of total debt and financial obligations.
Oriola-KD Oyj A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Oriola-KD Oyj A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Senheng New Retail Bhd
KLSE:5305
|
0.043x |
|
Elin Electronics Limited
NSE:ELIN
|
0.065x |
|
Tomei Consolidated Bhd
KLSE:7230
|
0.017x |
|
Alpha Pro Tech Ltd
NYSE MKT:APT
|
0.000x |
|
Llorente & Cuenca S.A.
MC:LLYC
|
0.283x |
|
Mercor S.A.
WAR:MCR
|
-0.262x |
|
Mobilicom Limited American Depositary Shares
NASDAQ:MOB
|
-0.330x |
|
Poznanska Korporacja Budowlana Pekabex SA
WAR:PBX
|
-0.137x |
Annual Cash Flow Conversion Efficiency for Oriola-KD Oyj A (2006–2024)
The table below shows the annual cash flow conversion efficiency of Oriola-KD Oyj A from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see OKDAV market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €133.40 Million ≈ $155.96 Million |
€38.70 Million ≈ $45.24 Million |
0.290x | +417.66% |
| 2023-12-31 | €171.30 Million ≈ $200.27 Million |
€9.60 Million ≈ $11.22 Million |
0.056x | -83.77% |
| 2022-12-31 | €225.60 Million ≈ $263.75 Million |
€77.90 Million ≈ $91.07 Million |
0.345x | +87.15% |
| 2021-12-31 | €216.80 Million ≈ $253.46 Million |
€40.00 Million ≈ $46.76 Million |
0.185x | -46.33% |
| 2020-12-31 | €169.60 Million ≈ $198.28 Million |
€58.30 Million ≈ $68.16 Million |
0.344x | -35.97% |
| 2019-12-31 | €157.20 Million ≈ $183.78 Million |
€84.40 Million ≈ $98.67 Million |
0.537x | -5.21% |
| 2018-12-31 | €181.50 Million ≈ $212.19 Million |
€102.80 Million ≈ $120.18 Million |
0.566x | +372.47% |
| 2017-12-31 | €197.70 Million ≈ $231.13 Million |
€23.70 Million ≈ $27.71 Million |
0.120x | -38.66% |
| 2016-12-31 | €205.20 Million ≈ $239.90 Million |
€40.10 Million ≈ $46.88 Million |
0.195x | -55.57% |
| 2015-12-31 | €194.60 Million ≈ $227.51 Million |
€85.60 Million ≈ $100.08 Million |
0.440x | +562.69% |
| 2014-12-31 | €113.60 Million ≈ $132.81 Million |
€-10.80 Million ≈ $-12.63 Million |
-0.095x | -188.72% |
| 2013-12-31 | €278.10 Million ≈ $325.13 Million |
€29.80 Million ≈ $34.84 Million |
0.107x | -26.80% |
| 2012-12-31 | €314.90 Million ≈ $368.15 Million |
€46.10 Million ≈ $53.90 Million |
0.146x | +55.93% |
| 2011-12-31 | €299.30 Million ≈ $349.91 Million |
€28.10 Million ≈ $32.85 Million |
0.094x | -62.67% |
| 2010-12-31 | €352.70 Million ≈ $412.34 Million |
€88.70 Million ≈ $103.70 Million |
0.251x | -33.95% |
| 2009-12-31 | €265.00 Million ≈ $309.81 Million |
€100.90 Million ≈ $117.96 Million |
0.381x | +490.22% |
| 2008-12-31 | €185.50 Million ≈ $216.87 Million |
€-18.10 Million ≈ $-21.16 Million |
-0.098x | -150.94% |
| 2007-12-31 | €203.60 Million ≈ $238.03 Million |
€39.00 Million ≈ $45.60 Million |
0.192x | -20.30% |
| 2006-12-31 | €191.80 Million ≈ $224.23 Million |
€46.10 Million ≈ $53.90 Million |
0.240x | -- |
About Oriola-KD Oyj A
Oriola Oyj provides healthcare and wellbeing products primarily in Sweden and Finland. It also offers vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products. In addition, it provides pharmaceutical logistics and dose dispensing services. Further, the company engages in the wholesale of traded goods and over-the counter products, and special licensed… Read more